AVBCC 2023 Summit

Session Highlights from AVBCC’s 13th Annual Educational Summit & Program

Changing legislation, emerging technologies, and rising costs are concerns for consumers and organizations alike. In the ever-changing oncology ecosystem, our conversations remain focused on value in oncology and proposed solutions for achieving it.

During the 13th AVBCC Educational Summit & Program, held October 18-20, 2023, in New York City, key stakeholders gathered to exchange knowledge and information with the goal of improving access, cost, and quality.

Highlights from the meeting included sessions on clinical trials and cancer research, emerging legislation, artificial intelligence (AI), and integrated supply channels. Remember, if you missed any of the exciting and informative sessions—or if you just want to revisit them—all the meeting content is archived and accessible to paid AVBCC Summit attendees for an entire year.


At the 13th Annual Association for Value Based Cancer Care Summit, held October 18-20, 2023, in New York City, Scott Gottlieb, MD, Former Commissioner of the FDA, gave the keynote lecture on how to foster innovation in oncology.
Read Article

In a session during the 13th Annual Summit of the Association for Value-Based Cancer Care, held October 18-20, 2023, in New York City, Linde Wilson, MBA, Managing Partner, HealthQuest Advisors, discussed the ongoing challenges related to the development and implementation of value-based agreements.
Read Article

Supply channels are becoming more and more complex, and their models are evolving with an abundance of services to support both the providers and suppliers. Such complexity is causing both challenges and opportunities in this arena. What does the future hold?
Read Article

Clinical trials have evolved over the years from gated phase 1, 2, and 3 approaches to more blended phase options and single-arm trials. However, we’re still seeing many of the same challenges, such as lack of patient access and diversity, similar or rising cost, and increasing complexity. Our panel of experts discussed the evolution of clinical trials and some unique solutions being considered for the future.
Read Article

From the Pharmacy Benefits Manager (PBM) Reform Act and 340B Drug Pricing Program to drug shortages and the Inflation Reduction Act, this panel of Washington healthcare experts separated fact from fiction and noise from reality to provide a clear understanding for current legislative priorities.
Read Article

Cancer treatments are advancing rapidly, thanks to the diligence of researchers and the foundations that support them. Panelists discussed emerging therapies, the impact of funding organizations, and what the future holds for the fight against cancers.
Read Article

Artificial intelligence (AI) and machine learning (ML) platforms are becoming essential to the value equation in healthcare and to managing the complexity and range of treatment options within cancer care today. Panelists in this session explored the application of AI and ML technologies and their impact on care, outcomes, cost, providers, pharma, payers, and patients as well as their integrations between electronic medical records and future systems.
Read Article